Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (30)

« Back to Publications

The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonists.

Napier S. et al, (2011), Bioorg Med Chem Lett, 21, 3163 - 3167

Development of a novel high-throughput assay for the investigation of GlyT-1b neurotransmitter transporter function.

Allan L. et al, (2006), Comb Chem High Throughput Screen, 9, 9 - 14

Investigating the potential role of oestrogen receptor beta (ER Beta) in affective disorders

Irving NG. et al, (2006), JOURNAL OF AFFECTIVE DISORDERS, 91, S84 - S84

Fe65 and X11beta co-localize with and compete for binding to the amyloid precursor protein.

Lau KF. et al, (2000), Neuroreport, 11, 3607 - 3610

Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease.

McLoughlin DM. et al, (1999), Eur J Neurosci, 11, 1988 - 1994

The Fe65 and X11 families of proteins: proteins that interact with the Alzheimer's disease amyloid precursor protein.

McLoughlin DM. et al, (1998), Biochem Soc Trans, 26, 497 - 500

lzheimer's disease, amyotrophic lateral sclerosis, and transgenic mice.

Bajaj NP. et al, (1998), J Neurol Neurosurg Psychiatry, 64, 711 - 715

Mapping of the human and murine X11-like genes (APBA2 and apba2), the murine Fe65 gene (Apbb1), and the human Fe65-like gene (APBB2): genes encoding phosphotyrosine-binding domain proteins that interact with the Alzheimer's disease amyloid precursor protein.

Blanco G. et al, (1998), Mamm Genome, 9, 473 - 475

Cellular mechanisms regulating phosphorylation of the neuronal cytoskeleton in normal and disease states.

Miller CCJ. et al, (1998), JOURNAL OF NEUROCHEMISTRY, 71, S55 - S55

Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes.

Brownlees J. et al, (1997), Neuroreport, 8, 3251 - 3255

Overexpression of the mouse dishevelled-1 protein inhibits GSK-3beta-mediated phosphorylation of tau in transfected mammalian cells.

Wagner U. et al, (1997), FEBS Lett, 411, 369 - 372

Tau phosphorylation in cells transfected with wild-type or an Alzheimer's disease mutant Presenilin 1.

Irving NG. and Miller CC., (1997), Neurosci Lett, 222, 71 - 74

mouse model for Down syndrome exhibits learning and behaviour deficits.

Reeves RH. et al, (1995), Nat Genet, 11, 177 - 184

BERRANT CYTOSKELETAL PHOSPHORYLATION AS A PATHOGENIC MECHANISM IN NEURODEGENERATIVE DISEASES - MECHANISMS OF CYTOSKELETAL PHOSPHORYLATION STUDIED IN CULTURED-CELLS AND TRANSGENIC ANIMALS

MILLER CCJ. et al, (1995), JOURNAL OF CELLULAR BIOCHEMISTRY, 100 - 100

COMPARATIVE PHYSICAL, RECOMBINATIONAL AND BIOLOGICAL MAPPING OF MOUSE CHR16 AND HUMAN CHR21 (HSA21)

REEVES RH. et al, (1995), CYTOGENETICS AND CELL GENETICS, 70, 180 - 181

Load More